Lead Physicians
Dr. Yair Levy
Hematology
Dr. Levy received his medical doctorate at the University of Wisconsin at Madison School of Medicine. He served his residency at the University of Pittsburgh Medical Center and his hematology fellowship at Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. He also served on the faculty at Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Dr. Levy currently serves as the director of Heme Malignancy Research at Baylor University Medical Center.
Dr. Andy Whiteley
Hematology
Dr. Whiteley practices at Texas Oncology as a Hematologist specializing in the treatment of benign and malignant hematologic disorders. He obtained his medical degree from the University of Arkansas for Medical Sciences, followed by residency and fellowship training at Baylor University Medical Center. He has served as an Adjunct Assistant Professor for the Texas AM College of Medicine.
Dr. Evan Lipson
Melanoma
Dr. Lipson is an internationally recognized skin cancer and immunotherapy specialist at Johns Hopkins. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease.
Dr. Johann Brandes
Lung Cancer
Dr. Johann Brandes received his MD degree from the University of Munich and his PhD degree from the University of Heidelberg. In addition, he holds a Masters degree in applied clinical informatics from Vanderbilt University. He completed residency training in internal medicine as well as fellowshiptraining in Medical Oncology and Pulmonary and Critical Care Medicine at Johns Hopkins Hospital. Subsequently, he served on the faculties of Johns Hopkins and Emory Universities with a special focus on the care patients with lung cancer. He has published extensively on both basic and clinical aspects of lung cancer prevention and treatment and has received numerous awards for his work. Currently, he serves as a medical oncologist with Tennessee Oncology in Murfreesboro, TN.
Dr. David Cosgrove
Gastrointestinal Cancer
Dr. Cosgrove is a Medical Oncologist at Compass Oncology, with offices in Portland, Oregon and Vancouver, Washington. He serves a co-chair of the GI Cancer Clinical Research Committee at USOR (US Oncology Research) and leads Phase 1 clinical trials at Compass. He has a broad clinical practice, with a focus on GI malignancies and clinical research. He serves as Principal Investigator on dozens of clinical trials, ranging from Phase 1 to Phase 3, and is involved with RWE trials through the Ontada group at US Oncology.
